Literature DB >> 10799818

Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system.

S Yamamura1, H Gotoh, Y Sakamoto, Y Momose.   

Abstract

We have found that the binary system, consisting of a precipitate of cimetidine and naproxen, became amorphous due to intermolecular interaction. In order to clarify the interaction between cimetidine and other drugs, the physicochemical properties of binary systems consisting of cimetidine and drugs, phenacetin, salicylamide or indomethacin, were investigated. X-ray powder diffraction patterns and thermal analysis findings for the precipitates indicated that the cimetidine-indomethacin system has an amorphous structure, whereas the cimetidine-phenacetin and cimetidine-salicylamide systems do not. Fourier-transform infra-red (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy findings suggested that there is an intermolecular interaction between a proton in the imidazole ring of cimetidine and the C=O in the COOH of indomethacin. Since an interaction by the hydrogen bond between cimetidine and indomethacin would prevent three-dimensional arrangements of the molecules, the precipitate would be amorphous. In the cimetidine-indomethacin system, decarboxylation of indomethacin occurred below the melting temperature, indicating that the chemical stability decreased upon precipitation. Cimetidine was found to interact with drugs with a carboxyl group. The interaction would be applicable to make the amorphous system of the drugs and increase the solubility of the drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799818     DOI: 10.1016/s0939-6411(00)00060-6

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations : Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li.

Authors:  Lærke Arnfast; Md Kamruzzaman; Korbinian Löbmann; Johanna Aho; Stefania Baldursdottir; Thomas Rades; Jukka Rantanen
Journal:  Pharm Res       Date:  2017-09-19       Impact factor: 4.200

Review 2.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.

Authors:  Anna Karagianni; Kyriakos Kachrimanis; Ioannis Nikolakakis
Journal:  Pharmaceutics       Date:  2018-07-19       Impact factor: 6.321

3.  Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.

Authors:  Ji-Hun An; Changjin Lim; Alice Nguvoko Kiyonga; In Hwa Chung; In Kyu Lee; Kilwoong Mo; Minho Park; Wonno Youn; Won Rak Choi; Young-Ger Suh; Kiwon Jung
Journal:  Pharmaceutics       Date:  2018-09-05       Impact factor: 6.321

Review 4.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.